Pharmaceutical Pipeline Enhancement Strategies Overview
- Year Founded
-
2007
- Status
-
Private
- Employees
-
19
- Latest Deal Type
-
Corporate
- Financing Rounds
-
1
Pharmaceutical Pipeline Enhancement Strategies General Information
Description
Provider of artificial intelligence fuelled clinical solutions intended to transform clinical development design, planning and delivery through the use of dynamically updated, real-world data analytics and insights. The company offers study planning, protocol design, trial rescue and site selection services, thereby helping biopharmaceutical companies with comprehensive clinical development analytical products and services.
Contact Information
Website
www.phesi.comCorporate Office
- PO Box 82
- East Lyme, CT 06333
- United States
Corporate Office
- PO Box 82
- East Lyme, CT 06333
- United States
Pharmaceutical Pipeline Enhancement Strategies Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Pharmaceutical Pipeline Enhancement Strategies Signals
Pharmaceutical Pipeline Enhancement Strategies Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Pharmaceutical Pipeline Enhancement Strategies FAQs
-
When was Pharmaceutical Pipeline Enhancement Strategies founded?
Pharmaceutical Pipeline Enhancement Strategies was founded in 2007.
-
Where is Pharmaceutical Pipeline Enhancement Strategies headquartered?
Pharmaceutical Pipeline Enhancement Strategies is headquartered in East Lyme, CT.
-
What is the size of Pharmaceutical Pipeline Enhancement Strategies?
Pharmaceutical Pipeline Enhancement Strategies has 19 total employees.
-
What industry is Pharmaceutical Pipeline Enhancement Strategies in?
Pharmaceutical Pipeline Enhancement Strategies’s primary industry is Medical Records Systems.
-
Is Pharmaceutical Pipeline Enhancement Strategies a private or public company?
Pharmaceutical Pipeline Enhancement Strategies is a Private company.
-
What is Pharmaceutical Pipeline Enhancement Strategies’s current revenue?
The current revenue for Pharmaceutical Pipeline Enhancement Strategies is .
-
How much funding has Pharmaceutical Pipeline Enhancement Strategies raised over time?
Pharmaceutical Pipeline Enhancement Strategies has raised $10M.
-
Who are Pharmaceutical Pipeline Enhancement Strategies’s investors?
Arcturis Data has invested in Pharmaceutical Pipeline Enhancement Strategies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process